Aim
To determine if incorporation of assessment of mechanical dyssynchrony could improve the prognostic value of patient selection based on current guidelines.
Methods and results
Echocardiography was performed in 1060 patients before and 12 ± 6 months after cardiac resynchronization therapy (CRT) implantation. Mechanical dyssynchrony, defined as the presence of apical rocking or septal flash was visually assessed at the baseline examination. Response was defined as > _15% reduction in left ventricular endsystolic volume at follow-up. Patients were followed for a median of 59 months (interquartile range 37-86 months) for the occurrence of death of any cause. Applying the latest European guidelines retrospectively, 63.4% of the patients had been implanted with a Class I recommendation, 18 .2% with Class IIa, 9 .4% with Class IIb, and in 9% no clear therapy recommendation was present. Response rates were 65% in Class I, 50% in IIa, 38% in IIb patients, and 40% in patients without a clear guideline-based recommendation. Assessment of mechanical dyssynchrony improved response rates to 77% in Class I, 75% in IIa, 62% in IIb, and 69% in patients without a guideline-based recommendation. Non-significant difference in survival among guideline recommendation classes was found (Log-rank P = 0.2). Presence of mechanical dyssynchrony predicted long-term outcome better than guideline Classes I, IIa, IIb (Log-rank P < 0.0001, 0.006, 0.004, respectively) and in patients with no guideline recommendation (P = 0.02). Comparable results were observed using the latest American Guidelines.
.. Conclusion
Our data suggest that current guideline criteria for CRT candidate selection could be improved by incorporating assessment of mechanical asynchrony.
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Introduction
Guidelines aim at translating inclusion criteria of high-quality clinical landmark trials into indications for treatment recommendations in order to guarantee a solid evidence base for the clinical practice. In the field of cardiac resynchronization therapy (CRT), the inclusion criteria of landmark trials that impacted the current recommendations for patient selection were left ventricular ejection fraction (< _30%, 1,2 < _35% 3, 4 , < _40% 5 ), New York Heart Association (NYHA) Class (I-II,  1,5 II,  4 II-III,  2 III,  3 II-IV,  6 III-IV   7,8 ), and QRS width (> _120 ms, 2,5 > _130 ms, 4,7,9 > _150 ms 3, 10 ). Recommendations have been further influenced by study results showing a better response of patients with left bundle branch block (LBBB) than non-LBBB morphology. 11 The suggested possible harm of CRT implantation in patients with QRS duration less than 130 ms by some studies 12 has led to increasing the threshold for CRT implantation from 120 ms in 2013 guidelines 13 to 130 ms in the 2016 edition of the European guidelines.
14 While this approach ensures a strong evidence base for a certain treatment, it does not necessarily guarantee the optimal strategy for patient selection, as relevant or potentially favourable selection criteria might not have been tested. In the case of CRT, which has become an established treatment option for patients with heart failure, left ventricular (LV) dysfunction and conduction delays, still approximately one-third of the patients remain non-responders to this costly and invasive therapy. 15 One such potential selection criterion, which is not considered in current guidelines is mechanical dyssynchrony. This is in particular due to the disappointing results of studies that tested the additional predictive value of parameters derived from the timing of longitudinal myocardial velocity peaks as surrogate of mechanical dyssynchrony, which failed to show any additional value over conventional guideline criteria despite promising results from single-centre studies. 16 In the meantime, however, there is growing evidence that advanced concepts such as the detection of specific motion patterns could be a potential guide for CRT candidate selection. 17, 18 The PREDICT-CRT trial investigated the association between CRT outcome and a novel parameter of mechanical dyssynchrony, characterized by a short septal contraction pulling the apex septally ['septal flash' (SF)] followed by a delayed lateral wall contraction which causes a lateral motion of the apex ['apical rocking' (ApRock)]. This specific pattern of contraction in addition to similar parameters which rely on the same phenomena, have been shown to be strongly associated with better survival and CRT response. 17, [19] [20] [21] [22] [23] [24] [25] [26] In this study, we relate current CRT guideline recommendations for patient selection with patient outcome and investigate the potential additive prognostic value of echocardiographic markers of mechanical dyssynchrony.
Methods

Study population
We analysed data from the PREDICT-CRT database 17 
Patient classification
For the current analysis, patients were retrospectively classified following the recommendations for CRT implantation as published in the 2016 European Society of Cardiology (ESC) guidelines for the diagnosis and treatment of acute and chronic heart failure 14 and according to the 2012 guideline published by the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society (ACCF/AHA/HRS). 23 First, we excluded data sets of 286 patients from our database, for which not all parameters used in the guideline classification scheme were available. The remaining data sets were then assigned to a guideline indication class when they met all criteria of that specific class. This assignment was performed by converting the guideline statements into Boolean expressions (Supplementary material online, Figure S1 ) and applying them to our database, thus avoiding any clinical interpretation of patient characteristics. In this way, 4.1% and 1.4% of patients were classified as Class III, while 4.9% and 9.4% of the patients remained unclassifiable according to the European and American guidelines, respectively. In the following text, these patients are referred to as CRT-not recommended (Supplementary material online, Figure S2 ).
Echocardiography
Patients underwent echocardiography before and 12 ± 6 months after CRT implantation. LV volumes and ejection fractions were measured using the modified biplane Simpson's method. Patients with LV endsystolic volume (LVESV) decrease of > _15% at the time of the follow-up visit were considered as volume responders. Mechanical dyssynchrony was visually assessed by analysing the presence of ApRock and SF (Supplementary material online, Videos S1 and S2). All echocardiographic measurements were performed by two experienced readers. A blinded third reader was asked in case of disagreement. 17 
Resynchronization therapy
All patients received biventricular pacing, in 399 (40%) with defibrillator (CRT-D). LV pacing leads were positioned, guided by coronary venography, preferably in the lateral and postero-lateral venous branches. Device settings were optimized within a week of CRT device implantation, as deemed clinically appropriate, based on surface electrocardiogram (ECG) or Doppler echocardiography. 24 
Statistical analysis
Continuous data are expressed as mean ± standard deviation. Normally distributed data were compared between groups using unpaired Student's t-test for continuous variables and v 2 test for categorical variables. If not normally distributed, median and interquartile range (IQR) and a Wilcoxon rank sum test were used. Survival rates were assessed using the Kaplan-Meier method, and differences in survival were compared between groups by a Log-rank test. Predictors of long-term survival were analysed in Cox's proportional hazards models. Data were processed using SPSS (IBM, Chicago, IL, USA) version 24.0. Two-sided P-value of <0.05 was considered significant. 
Results
Study population
Characteristics of the study population are summarized in Figure 1) . Patients who had to be excluded from this analysis due to missing data showed on average no significant difference in survival compared to the analysed study population (Supplementary material online, Figure S3 ). The intraobserver agreement for visual assessment of ApRock and SF had been reported earlier 17 
Volumetric response
From our study population, 65% of patients who had a Class I recommendation according to current European guidelines showed a volumetric response to CRT, 50% with Class IIa, 38% with Class IIb, and 40% of the CRT-not recommended (P < 0.0001, Figure 2 ). Comparable response rates were observed according to the American classification, 66% in Class I, 51% in Class IIa, 25% in Class IIb, and 40% in the CRT-not recommended (P < 0.0001, Supplementary material online, Figure S4 ). Adding mechanical dyssynchrony as an additional selection criterion to each guideline class led to a better discrimination between volume responders and non-responders within all European classes (77% in Class I, 75% in Class IIa, 62% in Class IIb, and 69% in the CRTnot recommended, Figure 3 ) and American guideline Classes I (76%), IIa (75%), IIb (75%), and the CRT-not recommended (70%), Supplementary material online, Figure S5 .
Survival analysis
During a median follow-up of 59 months (IQR 37-86 months), no significant difference was found in survival among patient's classes defined by the European guidelines (Log-rank P = 0.2). The survival of the classes defined by the American guidelines was significantly different between Classes I and IIa (P = 0.002) but not among the other classes ( Figure 4) . In both guidelines, there was no significant difference in survival between patients in whom CRT was recommended (Classes I, IIa, and IIb together) vs. those in whom it was not recommended ( Figure 5) .
For the entire study cohort, the presence of mechanical dyssynchrony before CRT implantation was associated with favourable outcome (Log-rank P < 0.0001) due to a lower all-cause mortality [hazard ratio (HR) 0.30, 95% CI 0.24-0.39; P < 0.0001, Figure 6 ]. Also within each European guideline recommendation class, the presence of mechanical dyssynchrony was associated with more favourable outcome (Log-rank P < 0.0001, 0.006, 0.004, 0.02 for Classes I, IIa, IIb, and the CRT-not recommended, respectively, Figure 7) due to a lower all-cause mortality (HR 0.21, 95% CI 0.15-0.30; P < 0.0001 in Class I; HR 0.47, 95% CI 0.27-0.82; P = 0.007 in Class IIa, HR 0.35, 95% CI 0.14-0.87; P = 0.02 in Class IIb, and HR 0.29, 95% CI 0.12-0.68; P = 0.004 in the CRT-not recommended). In American recommendation classes, mechanical dyssynchrony had a similarly favourable impact on outcome (Log-rank P < 0.0001, HR 0.40; 95% CI 030-0.54; P < 0.0001 for Class I; Log-rank P < 0.0001, HR 0.52; 95% CI 0.35-0.77; P = 0.001 for Class IIa; and Log-rank P 0.03; HR 0.37; 95% CI 0.18-0.76; P = 0.007 for the CRT-not recommended, Supplementary material online, Figure S6 ). 
Discussion
In this study, we retrospectively applied the latest European and American guideline recommendations for CRT implantation to a large database of CRT recipients. We found a relation between response rate to CRT and guideline recommendation class. The survival of patients with and without a recommendation for CRT implantation according to the current guidelines; however, was not significantly different. In each guideline recommendation class, mechanical dyssynchrony (ApRock and/or SF) was strongly associated with better volumetric response and more favourable patient outcome after CRT implantation. 
Guideline recommendation classes and volumetric response
We found a significant relation between guideline recommendation classes and volumetric response to CRT (Figure 2 and Supplementary material online, Figure S4 ). This behaviour might be expected, as a lower recommendation class should imply a lower likelihood that a certain therapy is effective.
Aiming at better identification of potential responders to CRT, the updates of the guidelines have introduced more strict criteria in Class I recommendation regarding QRS width and morphology. However, we found that 35% and 34% of patient with Class I recommendation according to the European and American guidelines, respectively, were non-responders. This observation is in concordance with other CRT studies which repetitively find a volumetric non-responder rate 
of around one-third of the implanted patients. 25 These nonresponders have significantly more often an ischaemic aetiology of heart failure, more scarred segments, a higher NYHA functional class, and less mechanical dyssynchrony (Supplementary material online, Tables S1 and S2). Although a lack of volumetric response does not necessarily equal a therapy failure, it is an indication that current recommendations for CRT implantation might lack specificity. Our analysis also revealed that 40% and 42% of the patients who were not recommended for CRT implantation according to current European and American guideline recommendations, respectively, showed a volume response. Most of these patients showed nonischaemic aetiology of cardiomyopathy and mechanical dyssynchrony at baseline (Dyss) echocardiographic examination (see supplementary subanalysis of the CRT-not recommended). This observation indicates a potential room for improving the sensitivity of the current guideline criteria.
Mechanical dyssynchrony and volumetric response
Mechanical dyssynchrony, on the other hand, was closely linked with volumetric response. For both guidelines, the additional consideration of mechanical dyssynchrony led to a better association with volumetric response in all recommendation classes (Figure 3 and Supplementary material online, Figure S5) .
Our data are in contrast to the predominant notion that the role of baseline mechanical dyssynchrony assessment might be of limited value in patients with LBBB and QRS > _ 150 ms (Class I recommendation), as these patients already have the largest likelihood of response. 5 We found, however, that even in this group, the selection of patients could be further improved when baseline mechanical dyssynchrony is considered in addition to the respective European and American guideline criteria (from 65% to 77% and from 66% to 76%, respectively).
Our data are also in contrast to the notion that patients with QRS duration between 120 and 150 ms are less likely to respond to therapy 26 which are classified depending on the pattern of the bundle branch block into Classes IIa and IIb by both guidelines. Considering mechanical dyssynchrony increased the number of correctly classified volume responders in the European recommendation Classes IIa by 25% and IIb by 24% and in the American guideline Class IIa by 24% and IIb by 50%. Our data are in-line with other studies, which have demonstrated an added prognostic value of mechanical dyssynchrony assessment in patients with moderately wide QRS complex (120-150 ms). 27 Guideline-based selection criteria, room for improvement
Our data show that specific signs of mechanical dyssynchrony, reflecting typical LBBB contraction pattern is closely linked to volumetric response regardless of QRS width. QRS width measurements have been shown to be associated with low reproducibility and high inter-and intraobserver variability, 28 which might in part explain patient miss-classifications and along with our findings doesn't make it the ideal surrogate to describe the mechanical dyssynchrony of the LV which is the pathophysiologic mechanism underlying the ventricular failure and the main target of a resynchronization therapy. Furthermore we were able to confirm the negative impact of a ischaemic aetiology of heart failure and scar burden, which has been shown to be associated with poor CRT response in addition to masking or modulating myocardial deformation patterns. 29, 30 Our data consequently suggest that the additional consideration of scar localization and extent would improve patient selection even further.
Guideline recommendation classes and patient survival
Our data showed a non-significant difference in survival between patients who were recommended for therapy according to the guidelines (recommendation Classes I, IIa, and IIb) and the CRT-not recommended, a finding that may indicate that there might be shortcomings in both specificity and sensitivity in the current guideline criteria. However, it is noteworthy that according to our analysis, 53% and 85% of CRT-not recommended patients were in fact unclassifiable mainly due to having EF > 35%, and showed on average a QRS width of 167 ± 20 ms and 151 ± 34 ms considering the European and American guidelines, respectively. It is therefore very likely, that those patients have an intraventricular dyssynchrony and will benefit from therapy despite of formally missing the EF cut-off for inclusion. Furthermore, CRT-not recommended patients were in better general condition compared to patients with other recommendation classes as reflected by higher EF and lower NYHA class at baseline examination which would improve their outcome 31 (EF: 34 ± 10 vs.
26 ± 6 and 36 ± 9 vs. 25 ± 5 and NYHA class 2.6 ± 0.7 vs. 3.0 ± 0.5 and 2.7 ± 0.8 vs. 3 .0 ± 0.5, P < 0.0001, for CRT-not recommended vs. other classes according to the European and American guidelines, respectively, see Supplementary material online for a detailed subanalysis of the CRT-not recommended).
On the other hand, adding mechanical dyssynchrony to both the European and the American guideline recommendations for CRT implantation was associated with more favourable survival and lower 
all-cause mortality. Our findings are in-line with other studies implementing the concept of LV mechanical dyssynchrony as selection criterion. 17, 27, [32] [33] [34] In all these studies, the proof of specific patterns of Dyss was associated with better survival after CRT than the summarized mortalities of CARE-HF, 8 COMPANION, 35 and MADIT-CRT. 36 Considering only patients with no baseline mechanical dyssynchrony, there was also non-significant difference in survival between guideline classes (Log-rank P = 0.17 and 0.24 for the European and American guideline classes, respectively, Supplementary material online, Figure S7 ). However, a tendency of worse outcome for patients with Class I indication in both guidelines might be noted at the first sight. This tendency may not only be attributed to the significantly worse general condition of Class I patients, as reflected by lower baseline EF and older age (EF: 27 ± 6 vs. 29 ± 7 and 26 ± 5 vs. 29 ± 7, and age 66 ± 8 vs. 63 ± 16 and 66 ± 8 vs. 63 ± 11; P < 0.05 for all comparisons for Class I vs. other classes according to the European and American guidelines, respectively, Supplementary material online, Tables S3 and S4) but also would shed some light on the potential undesirable outcome of CRT in patients who do not manifest true dyssynchrony that is amendable to therapy beyond ECG criteria, 19, 37 a finding that corresponds to consistently showing that one-third of patients do not respond to therapy in the previous studies. 15 
Future steps to improve selection of CRT candidates
Integrating both temporal and functional inhomogeneity, visual assessment of ApRock and SF has been shown to be superior to Doppler velocity-based assessments of mechanical dyssynchrony in predicting response to therapy, 38 overcoming their limitations and reflecting true LBBB contraction pattern. Previous data showed that ApRock and SF can be easily detected and yield comparable accuracy if quantitatively assessed. 17, 38, 39 Our data suggest that baseline assessment of ApRock and SF as a parameter of mechanical dyssynchrony could be a valuable supplement to the current guidelines resulting in better survival and increasing response rates. This strongly indicates Figure 7 The Kaplan-Meier curves depicting long-term survival after CRT implantation for each European recommendation class. Note that within each guideline recommendation class, the presence of baseline mechanical dyssynchrony (þDyss) was associated with a better long-term survival while its absence (-Dyss) was associated with less favourable outcome. N.R., not recommended for CRT implantation.
the need for a further investigation of specific mechanical dyssychrony parameters through larger prospective studies.
Study limitations
The study was retrospective and observational, leaving gaps in our knowledge, where a control group would have been needed. Although ethically difficult, only prospective randomized studies could fill these gaps and clarify with confidence the added value of specific mechanical dyssynchrony patterns.
In our study, we assessed echocardiographic volumetric response to therapy, other indices of clinical response like improvement of NYHA class or 6 min walk test were not investigated. Volumetric response was assessed after 1 year of device implantation which according to some publications may underestimate response rates due to potential late responders. 40 However, we have analysed longterm outcome data which are hard endpoints and might provide even more insight than a short-term volumetric or clinical response.
Conclusion
Our data indicate that current guideline criteria for CRT candidate selection leave room for improvement of both sensitivity and specificity. Incorporating the assessment of specific mechanical dyssynchrony patterns amendable by CRT is a promising tool to do so and should be considered for future evaluation through prospective randomized trials.
Supplementary data
Supplementary data are available at European Heart Journal -Cardiovascular Imaging online.
